Su Qingjie, Yuan Kunxiong, Long Faqing, Wan Zhongqin, Li Chaoyun, Cai Yi, Zeng Chaosheng, Wu Yingman, Wu Hairong, Liu Shu, Li Pengxiang, Zhou Jingxia, Chen Cong, Wang Desheng, Yan Limin, Zhang Yuhui, Dai Mingming
Vascular. 2014 Jun;22(3):181-7. doi: 10.1177/1708538113484022.
Survivors of ischemic stroke are still at a significant risk for recurrence. Numerous effective strategies for the secondary prevention of ischemic stroke have now been established; however, these guidelines are not widely known. In this retrospective, a multicenter study was conducted from January 2011 to February 2012 in 10 general hospitals, which included 1300 elderly patients who had previously been diagnosed with ischemic stroke and re-admitted to hospitals. Logistic regression models were fitted to determine the relationship between compliance with secondary prevention therapy and each variable of interest. The treatment rates of antihypertensive, antiplatelet and lipid-lowering therapy were only 56.3%, 48.9% and 19.6%, respectively. Multivariate analysis presented that cardiovascular risk factors would motivate patients with hypertension and hyperlipidemia to receive corresponding treatments. However, it is worth noting that they did not influence the use of antiplatelet therapy. In addition, high education, health education and insurance promote the use of secondary prevention in patients. In conclusion, the importance of antiplatelet therapy should not be ignored any more. Besides, health education will raise patients' attention to ischemic stroke.
缺血性中风幸存者仍面临较高的复发风险。目前已确立了许多有效的缺血性中风二级预防策略；然而，这些指南并未广为人知。在这项回顾性研究中，于2011年1月至2012年2月在10家综合医院开展了一项多中心研究，纳入了1300例既往诊断为缺血性中风且再次入院的老年患者。采用逻辑回归模型来确定二级预防治疗依从性与各感兴趣变量之间的关系。抗高血压、抗血小板和降脂治疗的使用率分别仅为56.3%、48.9%和19.6%。多变量分析表明，心血管危险因素会促使高血压和高脂血症患者接受相应治疗。然而，值得注意的是，这些因素并未影响抗血小板治疗的使用。此外，高学历、健康教育和医保促进了患者二级预防措施的采用。总之，抗血小板治疗的重要性不应再被忽视。此外，健康教育将提高患者对缺血性中风的关注度。
